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Introduction 
Cardiovascular infection include a group of conditions involving the heart muscle, 
the pericardium, the endocardial surface of the heart and the vessels. Infection can 
extend to prosthetic material or the leads in case of the implantation of devices or 
prosthesis. Despite their relative low incidence, all these conditions are associated 
with high morbidity and mortality, involving a relevant burden of diagnostic 
workup. In addition, due to the increase use of prosthetic valve, cardiovascular 
electronic device implants and vascular prosthesis the number of patient 
presenting with suspected infections is progressively rising. Early diagnosis is 
crucial for adequate management of patient, as early treatment improves the 
prognosis. Clinical onset of infection can be acute and severe: in this 
circumstance, diagnosis is straightforward and urgent surgery is generally 
required.  When clinical manifestation are non-specific, the diagnosis requires the 
correlation of imaging findings with laboratory data. Echocardiography in case of 
cardiac infections and ultrasound (US)/computed tomography (CT) in the case of 
vascular prosthesis are always performed as a first-line test. Magnetic Resonance 
(MR) imaging is also being increasingly employ because of the possibility for 
tissue characterization1. Microbiological data are essential to set the appropriate 
medical treatment. During the last years due to the increased availability of hybrid 
equipment (equipment where the CT/MR component is embedded with gamma 
camera or positron emission tomography (PET) equipment) this standard 
approach based on the use of morphological imaging has changed and functional 
multimodal imaging become the standard of care in several clinical conditions.  
A particular case of cardiovascular infections are the ones arising after the 
corrections of aorta defects with a special surgical approach, the Bentall 
procedure. This procedure positions a composite aortic graft (ie,, a vascular tube 
graft with an attached mechanical or biologic valve) to replace the proximal 
ascending aorta and the aortic valve. Circulation of the coronary arteries is 
maintained by implanting the proximal end of the coronary arteries into openings 
made in the aortic graft2. The procedure was first described by H.H. Bentall and 
A DeBono in 19683 and still performed today, despite some modifications4. 
Nowadays, the main treatment options for ascending aorta-aortic root associated 
with aortic valve disease include the Classic Bentall operation, the Cabrol 
Variation, and the Button Bentall procedure5, being the latest the most commonly 
performed6. The main indication for performing a Bentall surgery are the presence 
of aortic regurgitation, Marfan’s syndrome, aortic dissection, and aortic 
aneurysm. The entire procedure is normally completed in less than 5 hours7. In 
The Society of Thoracic Surgeons database, early mortality in adult patients 
undergoing root reconstruction with a valved-conduit (including patients with 
acute endocarditis and those operated on non-electively) operated between 2000 
and 2011 was 8.9%8. Possible complications associated with the Bentall 
procedure are represented by air embolus, arrhythmias, atelectasis, bleeding, 
pneumonia, transient confusion, wound infection, graft infection, embolization9. 
Rarely aortic abscesses can be present10. A recent meta-analysis, major adverse 
valve-related events are reported after the Bentall procedure with a cumulative 
incidence of 26.6% at 10 years, including major bleeding and thromboembolic 
complications, accounting for a combined cumulative incidence of 14.1% at 10 
years11. On the contrary, in the same paper low incidence of prosthetic valve 
endocarditis (IE) was reported. Infections after Bentall is reported in about 3% of 
the cases12. When thoracic aortic grafts is involved (VPI, about 2%)13 the ideal 
treatment consist in the replacement of the graft. However, this procedure carries 
a high mortality14, especially in cases of long-lasting infections or severe co-
morbidities. Other treatment options include graft salvage through aggressive 
debridement and irrigation or non-surgical management with antibiotics alone15. 
Still, the optimal treatment strategy is still controversial and there is not enough 
evidence to establish guidelines to manage this challenging problem. 
Mediastinitis is another important infectious complication in these patients, with 
an incidence ranging between 0.4 to 5% and very high mortality rate (27-50%)16. 
In the early postoperative period, the differential diagnosis of mediastinitis on the 
basis of imaging appearance alone is challenging, due to the presence of benign 
postoperative fluid and air collections in the surgical site. In fact, small amount of 
fluid or gas may be seen for several days or weeks after removal of mediastinal 
drains17. On CT, the presence of abnormally large amounts of low attenuation 
material surrounding the aortic graft or increasing fluid and soft tissue infiltration 
on serial scans and the presence of gas raise suspicion for mediastinitis18. The 
clinical presentation of fever, chest pain, and sepsis is also key to diagnosis of 
mediastinitis. Sternal Dehiscence and sternal wound infection may also occur 
alone or in association with mediastinitis19. CT findings in sternal dehiscence 
include displacement of sterna wires, sterna erosion, or cleft within the sternotomy 
site20.  
When isolated IE and VPI are present, molecular imaging techniques could be 
used to integrate the traditional diagnostic criteria and therefore fill such 
uncertainty gap with information on the biochemical burden of the endocardial 
/vascular infections. Two are the current techniques available: autologous 
radiolabeled leukocytes (WBC) SPECT/CT and [18F]FDG PET/CT. The first 
technique rely on the direct radiolabeling of autologous leukocytes that 
accumulate in a time-dependent fashion in late images vs earlier images in sites 
of infections. PET/CT is generally performed using a single acquisition time point 
(generally at 1h) after administration of [18F]FDG, which is actively incorporated 
in vivo by activated leukocytes, monocyte-macrophages, and CD4+ T-
lymphocytes presents or accumulating at the sites of infection. Less common 
PET/CT application involve the use of autologous leukocytes labeled by in vitro 
incubation with [18F]FDG, a more cumbersome procedure that is still in the phase 
of clinical validation. Very recently, these molecular imaging techniques ahas 
been incorporated in the European Society of Cardiology guidelines for the 
management of infective endocarditis (Figure 1)21. Anyway, no data have been jet 
produced on the possible use of these techniques in patients with infections 
erasing after the positioning of a composite aortic valve-root-thoracic aortic 
prosthesis with the Bentall surgical procedure. Therefore, in this study out of a 
large series of patients referred to our center for the diagnosis of cardiovascular 
infections, we assessed the diagnostic performances of WBC SPECT/CT and 
[18F]FDG PET/CT in the characterization of patients with suspected infection 
after the Bentall procedures.  
  
Materials and Methods 
 
Patient Population  
Between May 2005 and December 2015, out of a total of 622 patients referred for 
nuclear medicine procedures for suspected infection of the cardiovascular system 
(Table 1a), we selected 47 patients (13 women and 34 men, mean age 62.213.7 
years, median 66 years, range 29-83 years), with aortic valve and ascending aorta 
prosthesis. All the patients were surgically treated with replacement of the aortic 
valve and ascending aorta according to the Bentall procedure (mean time from the 
surgery 41.9 months, range 1 month-17 years). A total of 68 imaging procedures 
were performed: 99mTc-WBC scan (33 patients, 41 scans, 32 baseline scan and 9 
for antimicrobial treatment assessment) and/or [18F]FDG-PET/CT (20 patients, 27 
scans, 20 baseline scan and 7 for antimicrobial treatment assessment). A special 
group of patients (n=6) with very early/early infection defined as origination <3 
months after surgery, were studied with both procedures 2 days apart (Table 1b). 
All patients had undergone clinical examination, blood tests including WBC 
counts, CRP, ESR, acute phase proteins, electrophoresis, urinalysis. Three sets of 
blood cultures including at least one aerobic and one anaerobic from a peripheral 
vein were performed for all patients22. Other imaging tests include 
echocardiography (either transthoracic echocardiography (TTE) and 
transoesophageal echocardiography (TEE) alone or in combination, n=47), 
contrast enhanced (ce) cardiac-computerized tomography (CT, n=7), thorax ce-
CT (n=26), abdominal ce-CT (n=5) and magnetic resonance imaging (MRI) of 
the spine (n=2).The main clinical features and risk factors of the patients are 
summarized in Table 2.  
 Table 1a: number of patient that underwent 99mTc-WBC scintigraphy and 
[18F]FDG PET/CT from May 2005 and December 2015 for suspected 
cardiovascular infections 
 99mTc- WBC [18F]FDG PET/CT 
IE 136 125 
CIED infections 72 54 
VPI 145 37 
Bentall procedure 33* 20* 
Total number of patients 386 236 
*6 patients performed both WBC and PET 
IE = infective endocarditis , CIED = cardiovascular implantable electronic device , VPI = vascular 
prosthesis infections 
 
Table 1b: number of 99mTc-WBC scintigraphy and [18F]FDG PET/CT exams 
from May 2005 and December 2015 for suspected cardiovascular infections 
 99mTc- WBC [18F]FDG PET/CT 
 Baseline treatment 
evaluation 
baseline treatment 
evaluation 
IE 154 28 119 37 
CIED infections 124 29 55 8 
VPI 149 35 38 10 
Bentall procedure 32 9 18 9 
Total number of scans 459 101 230 64 
IE = infective endocarditis , CIED = cardiovascular implantable electronic device , VPI = vascular 
prosthesis infections.  
  
 Table 2: Summary of patients’ characteristics 
 
Age (years) Mean ± SD Median Range  
 62.2 ± 13.7 66 29-83  
Sex Women Men   
 13/47 (28%) 34/47 (72%)   
Risk factors Diabetes Renal failure Cutaneous lesions  
 9/47 (19%) 7/47 (15%) 2/47 (4%)  
Blood tests ESR CRP Leukocytosis  
 19/47(40%) 24/47 (51%) 4/47 (8%)  
Blood culture Positive Negative   
 17/47 (36%) 30/47 (64%)   
Duke criteria Definite Possible Rejected  
 3/68 (4%) 13/68 (19%) 52/68 (77%)  
     
Thorax-CT Positive Negative Inconclusive  
 4/36 (11%) 29/36 (81%) 3/36 (8%)  
Cardiac-CT Positive Negative Inconclusive  
 2/7 (29%) 4/7 (57%) 1/7 (14%)  
 
Time from surgery 
(month) 
≤1 
2/47 (4%) 
1-3 
4/47 (8%) 
4-12 
12/47 (26%) 
>12 
29/47 (62%) 
 
  
Ecocardiography 
TTE and TEE were performed as a standard procedure23. In particular, the 
presence of vegetations, abscesses, pseudoaneurysms, perforation, fistula valve 
aneurysm and of a dehiscence of the prosthetic valve were considered as major 
criteria for the presence of IE, according to the 2015 ESC Guidelines. 
Contrast-enhanced Computerized Tomography 
Thorax CT scanning was performed after administration of intravenous contrast 
by Multidetector CT. The following findings were considered predictive for the 
presence of IE: presence of vegetations, abscess, pseudoaneurysm and fistula24,25. 
The presence of fistula, pseudo-aneurysm, intergraft thrombus, hydronephrosis, 
perigraftic fluid, perigraft air, perigraft soft tissue attenuation were considered 
predictive for the presence of VPI26. 
Radiopharmaceuticals and Acquisition Protocols 
Radiolabelling of Autologous Leukocytes and Image Acquisition Protocol 
Autologous radiolabeled WBCs were prepared according to the EANM 
Guidelines for the labeling of leukocytes with 99mTc-HMPAO27,28Radiolabelling 
efficiency was always between 70-85%, and viability of the radiolabeled 
leukocytes was always tested by the Tripan-blue exclusion test before reinfusion. 
Whole body and spot planar images were obtained after 30 minutes (early), then 
4-6 and 20-22 hours (delayed images) after reinfusion of 370-555 MBq of 99mTc-
HMPAOWBC. SPECT/CT of the chest was performed in all patients at 6 hours 
and repeated at 20-22 hours in case of negative or doubtful imaging at 6hours. 
Images were acquired using a dual-head, variable-angle SPECT/CT gamma 
camera (Hawkeye, GE Healthcare or Discovery670). The low-dose CT 
transmission scan was acquired for 20 seconds over 220° for each transaxial slice 
in case of repetition of SPECT/TC images at 20-22 hr the scan was acquired at 
least 40 seconds for each slides. The full FOV consisting of 40 slices was 
completed in 10 minutes. The transmission data were reconstructed using filtered 
back projection to produce cross sectional images. Resolution of the CT scan was 
2.2 mm and localization images were produced with a 4.5-mm pixel size, similar 
to the nuclear medicine emission images. The CT scans were reconstructed into 
a256256 matrix. The SPECT component of the same FOV was acquired using a 
128128 matrix, 360° rotation, 6° angle step, and 40/60-sec-perframe acquisition 
time at 6 and at 24 hours, respectively. Both CT attenuation corrected and non-
corrected SPECT images were evaluate din the coronal, transaxial, and sagittal 
planes, as well as in tridimensional maximum intensity projection (MIP) cine 
mode. Matching pairs of x-ray transmission and radionuclide emission images 
were fused using the Xeleris software, and hybrid images of overlying 
transmission and emission data were generated. 
18F-fluoro-2-deoxyglucose ([18F]FDG) and Image Acquisition Protocol 
[18F]FDG (Gluscan®) was purchased either by GE or AAA and injected at a dose 
of about 3.7 MBq of [18F]FDG per kilogram body weight. As per the scanning 
protocol, the patients were instructed to fast for at least 6 h before undergoing 
examination, having be prepared with a high fat-very low-carboidrate, no sugar 
diet (Table 3) for the 24 hours before the scan.  
The blood sugar levels were checked prior to examination in order to confirm that 
they were within normal limits, but less strict criteria as compared to oncological 
patients were adopted in this case, as suggested by literature29,30. PET and CT 
images were acquired consecutively 60-90 minute after injection using a PET/CT 
system (Discovery 710; GE Heathcare). CT data were used for low-noise 
attenuation correction of PET emission data and for fusion with attenuation-
corrected PET images. PET data were reconstructed iteratively using ordered-
subset expectation maximization software. PET, CT, and fused PET/CT images 
were available for review and displayed in axial, coronal, and sagittal planes. 
  
Table 3: Diet to follow for the 24hours before the scan 
FOODS ALLOWED Foods NOT allowed 
All meats and poultry No cereals 
Hard cheese No pasta 
Non-starchy vegetables, such as: broccoli, 
spinach, green beans 
No dry beans 
Nuts and unsweetened peanut butter No fruit and fruit juices 
Diet soda and zero-calorie drinks. (Be careful to 
avoid caffeinated and decaffeinated drinks. 
Decaffeinate drinks still contain small amounts of 
caffeine). 
No sugar, honey, dessert, or candy.  
No breads, rice, gravies, no jams and jellies. 
No milk, or yogurt (including non-dairy milk 
Tofu No starchy vegetables, such as: peas, corn, 
potatoes 
Eggs No alcohol, coffee or tea 
Oil, margarine, butter No nutritional shakes or smoothies 
 
Interpretation Criteria 
Two experienced nuclear physicians aware of the patients’ clinical history and of 
the results of prior conventional imaging tests reviewed independently the planar 
scans-SPECT/CT images for WBC imaging and the PET/CT images, with regard 
to the presence and location of any focus of abnormal radioactivity accumulation 
indicating infection. Preliminary analysis of the SPECT/CT and PET/CT images 
included visual inspection to exclude misregistration between the SPECT and the 
CT components. The scintigraphic studies were classified as negative when no 
sites of abnormal uptake were observed at SPECT/CT or PET/CT images. Images 
where considered positive for infection when at least one focus of abnormal 
uptake characterized by time-dependent increase in radioactivity from early 
planar to delayed images was observed at WBC31. This time-dependent pattern of 
uptake is especially relevant for the cardiac region, considering that physiologic 
accumulation of radiolabeled leukocytes in the bone marrow (as in the sternum, 
overlying the heart) early after reinfusion can interfere with interpretation of the 
planar images. When present, focal uptake indicating infection was further 
classified as pertaining to the aortic valve (IE), to both aortic valve and aortic 
vascular prosthesis (IE associated with VPI) or to the aortic vascular prosthesis 
(VPI), to surrounding tissue (mediastinitis, sternum osteomyelitis) and/or to 
extracardiac sites (embolic events or other sites of concomitant infection). The 
contribution of SPECT/CT was considered with special attention to the possibility 
of anatomically localizing the exact site of infection, particularly for the heart 
region. In fact, neither the planar nor the stand-alone SPECT images allow to 
localize areas of focal uptake of the radiolabeled leukocytes in the cardiac region 
as pertaining or not to endocardium. 
For [18F]FDG PET/CT images the criteria considered for a positive scan was the 
presence of uptake in a region rather than the once of physiological uptake of 
intensity > surrounding tissue that persist at both AC and NAC images. Also in 
this case, when present focal uptake indicating infection was further classified as 
pertaining to the aortic valve (IE), to both aortic valve and aortic vascular 
prosthesis (IE with VPI) or to the aortic vascular prosthesis (VPI), to surrounding 
tissue (mediastinitis, sternum osteomyelitis) and/or to extracardiac sites (embolic 
events or other sites of concomitant infection). Based on the pattern of uptake the 
[18F]FDG PET/CT findings were further classify as i) positive with either diffuse 
or focal pattern of uptake and i) positive with focal pattern of uptake. In addition, 
based on the intensity and location of uptake as well as the time-length since the 
latest surgical procedures, findings consistent with post-surgical changes were 
excluded from the analysis. The Standard Uptake Value (SUV) mean and 
SUVmax values were calculated in all patients and compared in the following 
groups: positive and negative scans, patients with IE/without IE and patients with 
VPI/without VPI.  
 
 
 
 
Clinical classification: Duke’s criteria and new 2015 ESC diagnostic criteria  
for the diagnosis of IE  
Patients were classified according to the Duke’s criteria (Table 4). In addition 
after undergoing WBC SPECT/CT or [18F]FDG PET/CT a new classification 
according to the new 2015 ESC Criteria were also performed by incorporating the 
results of the molecular imaging tests (Table 5).  
  
Table 4: Summary of the Duke’s criteria 
MAJOR CRITERIA 
Blood colture positive for IE 
 Typical microorganism consistent with IE from 2 separate blood cultures: Viridans 
streptococci, Streptococcus bovis, Hacek group, Staphylococcus aureus; or Community 
acquire enterococci, in the absence of a primary focus; or 
 Microorganism consistent with IE from persistently positive blood cultures: at least  2 
positive blood cultures of blood sample drawn >12 apart; or all of 3 or a majority ≥4 separate 
cultures of blood (with first and last sample drawn at least 1 h apart) or 
 Single positive blood colture for Coxiella Burnetii or phase I IgG antibody tire ≥1:800 
 
Evidence of endocardial involvement 
 Echocardiography positive for IE (vegetation, abscess, new partial dehiscence of prosthetic 
valve 
 New valvular regurgitation 
MINOR CRITERIA 
 Predisposition such as predisposing heart condition, or injection drug use. 
 Fever defined as temperature >38°C 
 Vascular phenomena (including those detected only by imaging): major arterial emboli, 
septic pulmonary infarcts, infectious (mycotic) aneurysm, intracranial haemorrhage, 
conjunctivalhaemorrhages, and Janeway’s lesions. 
 Immunological phenomena: glomerulonephritis, Osler nodes, Roth’s spots, and rheumatoid 
factor 
 Microbiological evidence: positive blood culture but does not meet a major  criterion as noted 
above or serological evidence of active infection with organism consistent with IE. 
Diagnosis of IE is DEFINITE in the presence of: 
 2 major criteria or 
 1 major criteria and 3 minor criteria or 
  5 minor criteria 
Diagnosis of IE is POSSIBLE in the presence of: 
 1 major criteria and 1 minor criteria or 
  3 minor criteria 
  
Table 5: Summary of 2015 ESC modified criteria for diagnosis of IE:  
MAJOR CRITERIA 
Blood colture positive for IE 
 Typical microorganism consistent with IE from 2 separate blood cultures: Viridans 
streptococci, Streptococcus bovis, Hacek group, Staphylococcus aureus; or Community 
acquire enterococci, in the absence of a primary focus; or 
 Microorganism consistent with IE from persistently positive blood cultures: at least  2 
positive blood cultures of blood sample drawn >12 apart; or all of 3 or a majority ≥4 separate 
cultures of blood (with first and last sample drawn at least 1 h apart) or 
 Single positive blood colture for Coxiella Burnetii or phase I IgG antibody tire ≥1:800 
Imaging positive for IE: 
 Echocardiogram positive for IE (vegetation, abscess, pseudoaneurysm, intracardiac fistula, 
valvular perforation or aneurysm , new partial dehiscence of prosthetic valve 
 Abnormal activity around the site of prosthetic valve implantation detected  by 18F-FDG 
PET/CT or radiolabelled leukocytes SPECT/CT. (only if the prosthesis was implanted for >3 
months 
 Definite paravalvular lesions by cardiac CT 
MINOR CRITERIA 
 Predisposition such as predisposing heart condition, or injection drug use. 
 Fever defined as temperature >38°C 
 Vascular phenomena (including those detected only by imaging): major arterial emboli, 
septic pulmonary infarcts, infectious (mycotic) aneurysm, intracranial haemorrhage, 
conjunctivalhaemorrhages, and Janeway’s lesions. 
 Immunological phenomena: glomerulonephritis, Osler nodes, Roth’s spots, and rheumatoid 
factor 
 Microbiological evidence: positive blood culture but does not meet a major  criterion as noted 
above or serological evidence of active infection with organism consistent with IE. 
Diagnosis of IE is DEFINITE in the presence of: 
 2 major criteria or 
 1 major criteria and 3 minor criteria or 
  5 minor criteria 
Diagnosis of IE is POSSIBLE in the presence of: 
 1 major criteria and 1 minor criteria or 
  3 minor criteria 
  
Figure 1: Flow chart of the procedures recommended in case of suspected IE as 
reported in the European Society of Cardiology guidelines for the management of 
infective endocarditis. 
  
Data analysis 
Results of 99mTc-HMPAO-WBC scintigraphy including SPECT/CT and 
[18F]FDG PET/CT were correlated with those of Echocardiography/CT, blood 
culture and Duke criteria. Changes in the diagnostic classification of patients by 
including the results of WBC SPECT/CT or [18F]FDG PET/CT imaging were 
evaluated. The ability to detect or to exclude the presence of infection was based 
on the final microbiological or clinical diagnosis. Furthermore, the ability to 
identify peri-prosthetic infections as well as alternative cause of infections were 
considered, in order to assess the ability of 99mTc-HMPAO-WBC scintigraphy and 
[18F]FDG PET/CT to exclude IE/VPI. 
Statistical analysis 
All values are expressed as median and range, as customary for nonparametric 
data. The Pearson’s 2 test was employed for comparing parametric data between 
groups. Value of SUVmean and SUVmax values in positive/negative scans, 
IE/non-IE patients and VPI/non-VPI patients were correlated using the Mann 
Whitney U test. Sensitivity and specificity of the Duke classification and 99mTc-
HMPAO-WBC SPECT/CT and [18F]FDG PET/CT imaging were calculated 
based on the final diagnosis with 95% confidence intervals and compared using 
the McNemar test. Agreement between the Duke’s criteria and the 2015 New ESC 
Criteria was evaluated using the exact McNemar test.  
Results 
By adopting the interpretation criteria described above for scintigraphic detection 
of infection, it was possible to classify the scan as either frankly positive or frankly 
negative. With these criteria 99mTc-HMPAO-WBC scintigraphy was totally 
negative in 17/41. At least one abnormal area with pathological uptake of 
radiolabelled leukocytes was detected in 24/41 patients: 8 involving the aortic 
valve, 2 involving both aortic valve and the VPI and 5 the VPI. Extracardiac sites 
of infection either alone or associate with IE/VPI uptake were detected in 16 
cases, including sternum, lungs, bowel, spine and spleen. Overall 99mTc-HMPAO-
WBC scintigraphy sensitivity was 86%, specificity 85%, NPV 81%, PPV 89%, 
and accuracy 85% (Table 6). The highest number of FP and FN results was due 
to extracardiac infections, mainly due to small CNS, lung embolism and 
paravertebral extension of SD (n=3) and to unconfirmed spine findings (n=3), 
respectively. On the contrary, accuracy for diagnosis post-Bentall procedure 
complications range between 97-100%, being higher for aortic prosthetic 
component infection, either isolated or with concomitant extension to the aortic 
valve-root. Indeed, slightly lower sensitivity (89%) was shown for the detection 
of isolated aortic valve-root infection (Table 6).  
[18F]FDGPET/CT was totally negative in 8/27 patients. At least one abnormal 
area with significant increased uptake either diffuse or focal was detected in 19/27 
patients: 6 involving the aortic valve, 9 involving both aortic valve and the VPI 
and 3 the VPI; 11 were the sites of extracardiac involvement either alone or 
associate with IE/VPI uptake. Overall, sensitivity was 100%, specificity 53%, 
NPV 100%, PPV 63%, and accuracy 74%. (Table 7). 
False positive findings were found in patients who underwent surgery within 1 
month before the scan at both the aortic valve-root, the aortic graft and 
mediastinum (retrosternal collection). In addition, extracardiac sites of [18F]FDG 
uptake unconfirmed by follow-up scans were found in bowel, along peripheral 
vessels and at the spine. Increase [18F]FDG PET/CT accuracy (85%) was found 
by considering as positive scan the sole criteria of focal [18F]FDG uptake and 
excluding patients with early-surgery (<1 month). This figure is significantfor 
infection affecting the vascular portion of the prosthesis, but is not significantly 
impacting on[18F]FDG-PET/CT performances for diagnosis infection at the aortic 
valve/root as well as extracardiac sites (Table 7). SUVmax and SUV mean were 
significantly higher in the group of patients with positive scan and negative scan 
as well as in patients with IE and VPI as compared with patients without infections 
(Figure 2a-f, p< 0.001). 
Figure 2: Box plot showing the differences of SUVmax and SUVmean values in 
patients of the study when considering any site of uptake (a and b), uptake at valve 
site consistent with IE (c and d) and uptake in infected and non-infected VPI (e 
and f).  Differences were statistically different as demonstrated by Mann Whitneu 
U test (p< 0.0001). 
 
 
 
 
  
No significant differences in 99mTc-HMPAO-WBC and [18F]FDG PET/CT 
diagnostic performances were found in patients referred for a diagnostic scan and 
for antimicrobial treatment evaluation (see Table 8 and 9). Despite this latter 
represent a small group of patients, it is important to underline the absence of FN 
results, open the possibility to apply molecular imaging procedures in treatment 
decision making.  
In the group of patients with suspected very early post-surgical infections, 
comparative results of [18F]FDG PET/CT and 99mTc-HMPAO WBC were in 
agreement in 4 cases (1 negative and 3 positive), confirming the presence of 
infection whereas in 2 cases the positive [18F]FDG PET/CT finding were 
associated to a negative WBC findings. No signs of infections were found during 
patient’s follow-up. 
Table 10 shows the results of the Duke’s criteria in all patients of the study 
according to the results of 99mTc-HMPAO WBC and [18F]FDG PET/CT, 
respectively. In addition, Table 11 and 12 shows the results of the Duke criteria 
in 99mTc-HMPAO WBC and [18F]FDG PET/CT subdivided for the site of 
radiopharmaceuticals uptake. 
When incorporating results of 99mTc-HMPAO-WBC, [18F]FDG PET/CT findings 
into the Duke’s criteria as recommended in the 2015 New ESC Criteria, the major 
change is a decrease in the patients classified as Duke possible into definite or 
rejected category. Similarly, a significant decrease of the number of patients in 
the Duke rejected category is evident (Figure 3, Table 13 and 14).  
Table 10: Results of the Duke’s criteria in all patients based on the results of 99mTc-HMPAO-WBC or [18F]FDG PET/CT 
 Duke Definite Duke Possible Duke Rejected 
    
[18F]FDG PET/CT positive 1 5 10 
[18F]FDG PET/CT negative  1 10 
99mTc-HMPAO-WBC SPECT/CT positive 2 6 15 
99mTc-HMPAO-WBC SPECT/CT negative 1  17 
    
                             
                  Table 11: Results of the Duke’s criteria in 99mTc-HMPAO WBC based on the site of radiopharmaceutical uptake 
 
 
 
 
 
 
 
WBC 
n=23 
Aortic Valve VPI Aortic Valve+VPI Extracardiac 
 Isolated 
n=4 
+Extracardiac 
n=3 
Isolated 
n=2 
+Sternum +Mediastinum 
n=1 
+Extracardiac 
n=2 
 
n=2 
+Sternum +Mediastinum +Extracardiac n=9 
Duke 
Definite 
2 - - - - - - - - - - 
Duke  
Possible 
- 1 - - - 2 1 - - - 2 
Duke 
Reject 
2 2 2 - 1 - 1 - - - 7 
Table 12: Results of the Duke criteria in [18F]FDG PET/CT based on the site of radiopharmaceutical uptake 
 
 
 
 
 
 
 
 
 
PET/CT 
n=16 
Aortic Valve VPI Aortic Valve+VPI Extracardiac 
 Isolated 
n=1 
+ Extracardiac 
n=3 
Isolated 
n=1 
+Sternum +Mediastinum +Extracardiac 
n=2 
n=7 
 
+Sternum +Mediastinum 
n=1 
+Extracardiac 
n=1 
 
Duke  
Definite 
- - - - - - 1 - - - - 
Duke 
Possible 
- 3 - - - 1 1 - - - - 
Duke 
reject 
1 - 1 - - 1 5 - 1 1 - 
 Table 13: Results of the Duke criteria in all patients subdivided for the results of each nuclear imaging procedure 
 
 
 
 
 
  
 New ESC 2015 Definite  New ESC 2015 Possible New ESC 2015 Rejected 
    
[18F]FDG PET/CT positive 7 4 5 
[18F]FDG PET/CT negative   11 
99mTc-HMPAO-WBC SPECT/CT positive 8 5 10 
99mTc-HMPAO-WBC SPECT/CT negative  1 17 
 15 10 43 
Table 6: Overall data of 99mTc-HMPAO-WBC scintigraphy 
 Isolated 
IE 
IE+VPI VPI extracardiac total 
VP 8 2 5 13 24 
VN 27 40 37 27 17 
FP 0 0 0 3 3 
FN 1 0 0 3 4 
      
Sens 0,89 1,00 1,00 0,81 0,86 
Spec 1,00 1,00 1,00 0,90 0,85 
Acc 0,97 1,00 1,00 0,87 0,85 
VPP 1,00 1,00 1,00 0,81 0,89 
VPN 0,96 1,00 1,00 0,90 0,81 
 
Table 7: Overall data of [18F]FDG PET/CT 
 isolated 
IE 
IE+VPI VPI extracardiac total 
VP 4 6 2 6 12 
VN 21 18 24 16 8 
FP 2 3 1 5 7 
FN 0 0 0 0 0 
      
Sens 1,00 1,00 1,00 1,00 1,00 
Spec 0,91 0,86 0,96 0,76 0,53 
Acc 0,93 0,89 0,96 0,81 0,74 
VPP 0,67 0,67 0,67 0,55 0,63 
VPN 1,00 1,00 1,00 1,00 1,00 
 
 
 
 
 
 
 
 
 
 
Table 8a: performances of 99mTc-HMPAO-WBC evaluation in patients who 
underwent the scan in basal conditions 
 
 
 
 
 
 
 
 
Table 8b: performances of 99mTc-HMPAO-WBC in patients who underwent the 
scan for therapy evaluation 
 IE IE+VPI VPI extracardiac total 
VP 1 0 2 2 4 
VN 3 7 5 5 3 
FP 0 0 0 1 1 
FN 0 0 0 1 1 
      
Sens 1,00 - 1,00 0,67 0,80 
Spec 1,00 1,00 1,00 0,83 0,75 
Acc 1,00 1,00 1,00 0,78 0,78 
VPP 1,00 - 1,00 0,67 0,80 
VPN 1,00 1,00 1,00 0,83 0,75 
 
 
 
 
 
 
 
 
 
 isolated 
IE 
IE+VPI VPI extracardiac total 
VP 6 2 3 12 20 
VN 27 31 30 21 13 
FP 0 0 0 2 2 
FN 1 0 0 2 3 
      
Sens 0,86 1,00 1,00 0,86 0,87 
Spec 1,00 1,00 1,00 0,91 0,87 
Acc 0,97 1,00 1,00 0,89 0,87 
VPP 1,00 1,00 1,00 0,86 0,91 
VPN 0,96 1,00 1,00 0,91 0,81 
Table 9a: performances of [18F]FDG PET/CT evaluation in patients who 
underwent the scan in basal conditions 
 isolated 
IE 
IE+VPI VPI extracardiac total 
VP 4 5 2 6 12 
VN 22 20 24 18 11 
FP 1 2 1 3 4 
FN 0 0 0 0 0 
      
Sens 1,00 1,00 1,00 1,00 1,00 
Spec 0,96 0,91 0,96 0,86 0,73 
Acc 0,96 0,93 0,96 0,89 0,85 
VPP 0,80 0,71 0,67 0,67 0,75 
VPN 1,00 1,00 1,00 1,00 1,00 
 
Table 9b: performances of [18F]FDG PET/CT in patients who underwent the 
scan for therapy evaluation 
 isolated 
IE 
IE+VPI VPI extracardiac total 
VP 0 1 0 0 1 
VN 6 5 0 5 4 
FP 1 1 0 2 3 
FN 0 0 0 0 0 
      
Sens - 1 -  1 
Spec 0,86 0,83 - 0,71 0,57 
Acc 0,86 0,86 - 0,71 0,63 
VPP 0,00 0,50 - 0,00 0,25 
VPN 1,00 1,00 - 1,00 1,00 
Table 10: Results of the Duke’s and New 2015 ESC criteria in all the patients of 
the study 
 
  Duke’s 
criteria 
 
 Definite Possible Rejected 
 Definite 3 7 5 
New 2015 ESC criteria Possible   10 
 rejected  6 37 
  
Figure 3: Changes in the classification of patients in the three main category of 
the Duke’s criteria by adding the finding of “abnormal activity around the site of 
prosthetic valve implantation” detected by [18F]FDG PET/CT or 99mTc-
HMPAO-WBC SPECT/CT  
 
Duke’s criteria 
Definite n=3 
Rejected n=43 Rejected n=52 
Possible n=10 Possible =13 
Definite n=15  
5 
 
7 
New ESC 2015 
criteria 
6 
10
0
    
Fig. nXXX:  
a)aspecific FDG 
uptake (aortic 
valve+VPI) 
b) No WBC uptake 
(aortic valve+VPI) 
Figure 4: example of a patients who underwent [18F]FDG PET/CT 
(upper panel, coronal view from left to right CT, emission and 
superimposed PET/CT)  and 99mTc-HMPAO-WBC (lower panel, 
coronal view from left to right CT, emission and superimposed 
SPET/CT) 1 months after substitution of the aortic valve-root and 
thoracic aorta with the Bentall procedure. Increase uptake of 
[18F]FDG is evident of PET/CT images at both the aortic valve and 
the vascular graft with a diffuse pattern of uptake, despite area of 
focal accumulation are seen. The corresponding WBC images 
show a normal pattern of uptake. Patients was observed for 2 years 
and during follow up no sign/symptoms of infection were noticed.  
 
 
   
 
Figure 5: example of a patients who underwent [18F]FDG 
PET/CT (upper panel, assial view at two different levels from left 
to right CT, emission and superimposed PET/CT)  and 99mTc-
HMPAO-WBC (lower panel, assial view from left to right CT, 
emission and superimposed SPET/CT) 1 months after 
substitution of the aortic valve-root and thoracic aorta with the 
Bentall procedure. Diffuse increase uptake of [18F]FDG is evident 
of PET/CT images at sternum. The corresponding WBC images 
show a normal pattern of uptake. The patient was observed for 2 
years and during follow up no sign/symptoms of infection were 
noticed. 
  
   
Figure 6: Example of [18F]FDG PET/CT transaxial images (from top to bottom 
emission, CT and superimposed PET/CT) of the left ventricular uptake in patient 
who underwent [18F]FDG PET/CT without the correct preparation with the HFLC 
(left and central panel) that impaired the correct evaluation of the aortic valve plan. 
After 24hrs HFLC diet and 6 hrs fasting, myocardial [18F]FDG is significantly 
decrease and an area of radiopharmaceutical uptake consistent with infection 
correctly depicted at the images (right panel). 
  
Figure 7: Examples of different pattern of [18F]FDG uptake in 
patient who underwent [18F]FDG PET/CT (transaxial view 
from left to right emission, CT and superimposed PET/CT) :  
diffuse and linear [18F]FDG uptake in the aortic root (a); focal 
[18F]FDG uptake in VPI linear (b); [18F]FDG uptake at aortic 
valve (c and d); focal [18F]FDG uptake at anterior 
mediastinum/retrosternal space in an abscess.  
 
a 
b 
c 
d 
e 
  
Figure 8: example of extracardiac uptake at PET/CT images (transaxial 
view from left to right CT, emission and superimposed PET/CT) at 
baseline (upper panel) and for treatment monitoring (lower panel). Images 
clearly shoes a spleen site of uptake (embolism) disappearing after 
treatment (example of good response). 
Discussion 
In this study, we evaluated a series patients with a clinical suspicious infection 
after replacement of the aortic valve and the thoracic aorta according to the Bentall 
procedure, who underwent either WBC or PET/CT procedures. Despite the risk 
of infection is this patients is relatively low, not exceeding 5% of patients32, when 
infection is present diagnosis is challenging and associated with high mortality. 
In fact, infection might presents with aortic valve-root involvement or with 
infection localized to the vascular aortic graft. Those two conditions might also 
coexist and involve the surrounding structure such as the mediastinal soft tissue 
and the sternum. No specific guidelines for the management of aortic valve-root-
vascular prosthesis infections are available, being usually followed the standard 
recommendations for diagnosis infectious endocarditis and prosthetic graft 
infections, including echocardiography and ce-CT and/or MRI in short interval. 
During the latest years, evidence has grown of the use of nuclear medicine 
procedures such as WBC scan and [18F]FDG PET/CT for the management of 
infections of prosthetic valve and vascular prosthesis. Therefore, the possibility 
of applying in this specific clinical setting is intriguing. Indeed, the recent 2015 
ESC guidelines the evidence of endocardial involvement at either WBC or 
[18F]FDG PET/CT (or at Ce-CT) has been introduced as a major criteria in the 
attempt to increase the sensitivity of the Duke’s criteria, which include 
echocardiography as the only imaging test. On the basis of the extensive 
experience in multimodality imaging in IE and VPI, we decided to apply WBC 
SPECT/CT and/or [18F]FDG PET/CT in this group of patients by imaging all 
patients with a suspected infection after Bentall procedure with one of these two 
imaging test irrespectively from any clinical feature. In our hands, the diagnostic 
accuracy of both WBC and [18F]FDG PET/CT in this special population does not 
differ significantly for what reported in case of IE and peripheral VPI. As for 
PET/CT, due to the well known limitation of [18F]FDG as infection-specific agent, 
there is the clinical need of developing standardized imaging interpretation 
criteria in the attempt to increase the procedure specificity. Therefore, in this study 
we analyzed the performances of several interpretation criteria taking into account 
the location, the pattern and the intensity of [18F]FDG uptake. In this series the 
presence of uptake at the vascular prosthesis characterized by focal pattern of 
uptake and SUVmax > 3 are the parameters with the higher likelihood to predict 
infection (specificity 96%). On the contrary, for diagnosis IE, the presence of 
focal pattern of uptake as interpretation criteria for a positive scan was not 
associated with increase specificity. This is in line with similar findings we have 
recently reported on patients with IE and CIED infections, where the pattern of 
diffuse and focal uptake with SUVmax > 5 and a valve/lung ratio>8 were equally 
able to define the presence of IE (Boni et al. EANM 2016). In the study, increased 
specificity was found only when excluding from the analysis patients with 
infection erased very early/early after surgery (< 1 months). In fact, out of the 6 
patients with very early infection sin two cases a positive PET performed was not 
corresponding to a positive WBC SPECT/CT performed 2-days apart (see an 
example in Figure 4). Time from surgery was not significantly affecting any of 
the results at WBC. These finding are consistent with the results reported by 
Rouzet et al33, reinforcing the evidence that caution should be taken when imaging 
patients early after surgery, where a preferential use of WBC SPECT/CT might 
be suggested.  
It’s well known that the pattern of [18F]FDG uptake might help in increasing the 
specificity of [18F]FDG PET/CT in VPI. Israel et all34 in a retrospect study showed 
that diffuse [18F]FDG uptake was found in 92% of non-infected vascular 
prosthesis, higher in Dacron grafts than with other material.  The intensity of 
[18F]FDG uptake in synthetic grafts did not change over time. The intensity of 
[18F]FDG uptake in synthetic grafts did not change over time. Knowledge of the 
presence, patterns, and persistence of [18F]FDG uptake in non infected vascular 
prostheses will aid in avoiding the misinterpretation of PET/CT studies in patients 
assessed for diseases unrelated to their graft status and in those referred for 
suspected prosthetic infection. 
In our experience, when performing PET/CT appropriate patients preparation is 
as critical as the imaging interpretation. In fact, the identification of FDG uptake 
at the aortic valve-root might be accomplished just in case of adequate glucose 
myocardial uptake suppression. It’s well known that variable focal of diffuse 
physiologic [18F]FDG uptake is often observed in the normal myocardium of 
fasting nondiabetic patients (6-12 hours to overnight) with normal glucose levels. 
Accumulation of [18F]FDG is most notable in the left ventricular myocardium, 
which has a greater muscle mass than other cardiac chambers. Uptake in the wall 
of the right ventricle is typically equal to or less intense than that in the left 
ventricular myocardium; uptake in the wall of the right and left atria is usually not 
detected. Factors possibly influencing myocardial uptake of [18F]FDG include 
patients' age, fasting time, blood glucose levels, and a low-carbohydrate diet. In 
particular, while age and fasting time do not affect physiologic [18F]FDG uptake 
in the myocardium, blood glucose levels may have a nonlinear effect on 
myocardial uptake. In literature there are several protocols used for patients’ 
preparations including short-to-long-term fasting, low or no carbohydrate 
combined with high-fat content, by using a combination of fasting and ingestion 
of high fat meals, or (co)administration of heparin35,36,37,38,39,40,41,42,43,44,45. Fasting 
for 4-12 hours is used in many protocols although more prolonged fasting (18 
hours or more) may improve the detection of lesion46. The utilization of very high-
fat, low-carbohydrate, protein-permitted (VHFLCPP) diet has been shown to be 
effective in suppressing myocardial [18F]FDG uptake38,47. Finally, provision of 
higher circulating concentrations of fatty acid-rich triglycerides through the 
intravenous injection of up to 50 IU/kg of heparin is used by some groups to 
inhibit physiological myocardial glucose uptake 44,48,49. The use of heparin with a 
relatively short fasting period (12 hours), however, does not inhibit myocardial 
glucose uptake to the same extent as a prolonged (18 hour) fast, and results 
differ10. Special attention must be paid to diabetic patients because insulin and 
oral hypoglycemic agents stimulate glucose uptake by the myocardium. In this 
study we decided to prepare patients according to the SNMMI/ASNC/SCCT 
guidelines by a fat-enriched diet lacking carbohydrates for 12-24 hours prior to 
the scan, a 12-18 hour fast50. We did use of intravenous heparin administration 
prior to 18F-FDG injection. By using this protocol we were able to evaluate all 
the scans. 
As expected, the use of the Duke criteria for diagnosis infection after the Bentall 
procedure is limited by their lack of specific criteria for evaluating the vascular 
component of the prosthesis. By applying the new ESC 2015 diagnostic criteria 
which embedded results of WBC or PET/CT scan (and the same is most likely 
foreseen for ce-CT in case of positivity) a significant increase of patients 
classified as Definite is obtained along with the substantial re-classification of the 
patients classified as possible. 
Also in presence of infection after Bentall procedure the risk of distant sites of 
infections should not be underestimated. In the present study infection rather than 
in the prosthetic valve-root-graft was found in about 45% of patients, both as 
embolic events or concomitant source of infection/inflammation. A typical 
example of this occurrence is represented by patients affected by large vessel 
vasculitis who presented fever and increased CRP/ESR or patients with 
orthopedic prosthesis or CIED. Thanks to the unique whole body exploiting 
possibility of PET/CT and/or WBC SPECT/CT a differential diagnosis might be 
reached, impaction on the consequent patients’ management. Such 99mTc-
HMPAO-WBC and [18F]FDG PET/CT impact on patients’ management was not 
present only in patients referred for diagnostic scans, but also when the procedure 
was request for antimicrobial treatment evaluation. Two were the main indications 
for the referral of these patients: i) defining the evolution of the infection in 
patients who, despite appropriate antimicrobial treatment, did not shown 
significant biochemical response and ii) evaluate disease activity at the end of the 
standard 6 weeks in presence of high risk patients. Despite this latter represent a 
small group of patients, it is important to underline the absence of FN results, a 
finding that open the possibility to apply molecular imaging procedures also in 
treatment decision making.  
 
Conclusions 
Results of this study support the use of 99mTc-HMPAO-WBC SPECT/CT and 
[18F]FDG PET/CT in patients with high clinical suspicion of IE and/or VPI after 
Bentall procedure, in order to confirm the diagnosis in doubtful cases. Additional 
circumstances where we found useful performing the imaging procedures are 
antimicrobial therapy assessment and the detection of other sites of infections. 
The diagnostic accuracy of both 99mTc-HMPAO-WBC and [18F]FDG PET/CT in 
this special population does not differ significantly for what reported in case of IE 
and peripheral VPI. We found a specific pattern and intensity of [18F]FDG 
associated with the higher likelihood to predict infection. On the contrary, we 
were not able to define a specific pattern of uptake significantly associated with a 
the presence of IE.  
Based on our experience, 99mTc-HMPAO-WBC should be the first choice 
procedure early after surgery. [18F]FDG PET/CT using specific interpretation 
criteria present acceptable specificity in patients with both IE and VPI, therefore 
representing the first choice method in compromise patients. 
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